Literature DB >> 12891835

Current controversies in the understanding of necrotizing enterocolitis. Part 1.

Barbara Noerr1.   

Abstract

Necrotizing enterocolitis (NEC) has widespread implications for neonates. While mostly affecting preterm neonates, full-term neonates, especially those with congenital heart disease, are also at risk. Although the exact pathogenesis of NEC remains elusive, three major factors, a pathogenic organism, enteral feedings, and bowel compromise, coalesce in at-risk neonates to produce bowel injury. Initiation of the inflammatory cascade likely serves as a common pathway for the disorder. Clinical signs and symptoms range from mild feeding intolerance with abdominal distension to catastrophic disease with bowel perforation, peritonitis, and cardiovascular collapse. Vigilant assessment of at-risk neonates is crucial. When conservative medical management fails to halt injury, surgical intervention is often needed. Strategies to decrease the incidence and ultimately prevent NEC loom on the horizon, such as exclusive use of human breastmilk for enteral feedings and administration of probiotics.

Entities:  

Mesh:

Year:  2003        PMID: 12891835     DOI: 10.1016/s1536-0903(03)00072-9

Source DB:  PubMed          Journal:  Adv Neonatal Care        ISSN: 1536-0903            Impact factor:   1.968


  11 in total

1.  Signal transduction pathways involved in oxidative stress-induced intestinal epithelial cell apoptosis.

Authors:  Yuning Zhou; Qingding Wang; B Mark Evers; Dai H Chung
Journal:  Pediatr Res       Date:  2005-12       Impact factor: 3.756

2.  Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation.

Authors:  Katherine E Gregory; Christine E Deforge; Kristan M Natale; Michele Phillips; Linda J Van Marter
Journal:  Adv Neonatal Care       Date:  2011-06       Impact factor: 1.968

Review 3.  Necrotizing enterocolitis: a practical guide to its prevention and management.

Authors:  Pinaki Panigrahi
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 4.  Multi-modal approach to prophylaxis of necrotizing enterocolitis: clinical report and review of literature.

Authors:  G Schmolzer; B Urlesberger; Michaela Haim; J Kutschera; G Pichler; E Ritschl; B Resch; F Reiterer; W Müller
Journal:  Pediatr Surg Int       Date:  2006-06-15       Impact factor: 1.827

5.  The effect of vascular endothelial growth factor overexpression in experimental necrotizing enterocolitis.

Authors:  Hande Ozgun Karatepe; Huseyin Kilincaslan; Mustafa Berber; Ahmet Ozen; Hulya Ercan Saricoban; Duran Ustek; Ahu Sarbay Kemik; Mine Adas; Filiz Bakar
Journal:  Pediatr Surg Int       Date:  2014-01-01       Impact factor: 1.827

6.  Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management.

Authors:  J M Brooks; J N Travadi; S K Patole; D A Doherty; K Simmer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

Review 7.  New insights into the pathogenesis and treatment of necrotizing enterocolitis: Toll-like receptors and beyond.

Authors:  Amin Afrazi; Chhinder P Sodhi; Ward Richardson; Matthew Neal; Misty Good; Richard Siggers; David J Hackam
Journal:  Pediatr Res       Date:  2011-03       Impact factor: 3.756

Review 8.  Insights into virulence factors determining the pathogenicity of Cronobacter sakazakii.

Authors:  Niharika Singh; Gunjan Goel; Mamta Raghav
Journal:  Virulence       Date:  2015-05-07       Impact factor: 5.882

9.  Protective Effects of Bifidobacterium on Intestinal Barrier Function in LPS-Induced Enterocyte Barrier Injury of Caco-2 Monolayers and in a Rat NEC Model.

Authors:  Xiang Ling; Peng Linglong; Du Weixia; Wei Hong
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

10.  Persistent Ductus Arteriosus in Critically Ill Preterm Infants.

Authors:  Maria Livia Ognean; Oana Boantă; Simona Kovacs; Corina Zgârcea; Raluca Dumitra; Ecaterina Olariu; Doina Andreicuţ
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.